Controlling the Duration of Fibrin Scaffold in vivo Absorption
Symposium on Biologic Scaffolds for Regenerative Medicine · Napa Valley, California
Controlling fibrin longevity
Fibrin-based systems use blood plasma-derived proteins in surgical sealants, hemostasis and tissue engineering. Our work explores protease inhibitors and sustained release to extend the persistence of fibrin clots and scaffolds.
View protease inhibitor patents
Antivirals & antifibrinolytics
Our published application describes a system and method for delivering inhibitors aimed at preventing the entry of SARS-CoV-2 and emerging variants.
Read the published application (PDF)
Scientific presentations
Calcium Tranexamate: A Novel Protease Inhibitor and Hemostat
TERMIS-AM · Washington, DC
Improving Longevity of Fibrin Sealant In Vivo Absorption by Sustained Release Inhibitor
TERMIS-AM · Washington, DC
Protease Inhibitors from Derivatives of Tranexamic Acid
252nd ACS National Meeting & Exposition · Philadelphia, Pennsylvania